← back to search

Jason D. Merker

University of North Carolina at Chapel Hill · US
Area of research
Cancer Research · Genetics
Research interest
Research interests include Cancer Genomics and Diagnostics, Genomics and Rare Diseases, Genetic factors in colorectal cancer, and Acute Myeloid Leukemia Research.
h-index
34
citations
7,391
works
106
NIH funding
primary concept
Medicine
email

Recent publications

ESMO recommendations on the use of circulating tumour DNA assays for patients with cancer: a report from the ESMO Precision Medicine Working Group
Annals of Oncology 2022cited by 633position: middledoi
Standards for the classification of pathogenicity of somatic variants in cancer (oncogenicity): Joint recommendations of Clinical Genome Resource (ClinGen), Cancer Genomics Consortium (CGC), and Variant Interpretation for Cancer Consortium (VICC)
Genetics in Medicine 2022cited by 229position: middledoi
PPA2-associated sudden cardiac death: extending the clinical and allelic spectrum in 20 new families
Genetics in Medicine 2021cited by 26position: middledoi
Lymphoid blast transformation in an MPN with <i>BCR-JAK2</i> treated with ruxolitinib: putative mechanisms of resistance
Blood Advances 2021cited by 21position: middledoi
Identification of rare-disease genes using blood transcriptome sequencing and large control cohorts
Nature Medicine 2019cited by 350position: middledoi
Designing and Implementing NGS Tests for Inherited Disorders
Journal of Molecular Diagnostics 2018cited by 29position: middledoi
The impact of rare variation on gene expression across tissues
Nature 2017cited by 291position: middledoi
Comparison of Laboratory-Developed Tests and FDA-Approved Assays for <i>BRAF, EGFR,</i> and <i>KRAS</i> Testing
JAMA Oncology 2017cited by 36position: middledoi
College of American Pathologists' Laboratory Standards for Next-Generation Sequencing Clinical Tests
Archives of Pathology & Laboratory Medicine 2014cited by 399position: middledoi
Assuring the quality of next-generation sequencing in clinical laboratory practice
Nature Biotechnology 2012cited by 468position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Patricia Vasalos · University of Colorado Denver2 papers (2017–2018)Birgit Funke · Children's Hospital of Philadelphia2 papers (2014–2018)Stephen B. Montgomery · Stanford Medicine2 papers (2017–2021)Karl V. Voelkerding · Walker (United States)2 papers (2014–2018)Farhan N. Damani · Stanford University1 papers (2017–2017)Klaus Pantel · Landesinstitut für Lehrerbildung und Schulentwicklung1 papers (2022–2022)Sanjay Popat · Royal Marsden NHS Foundation Trust1 papers (2022–2022) · 1 papers (2018–2018)Alexander J. Lazar · Disco (Germany)1 papers (2017–2017)Yungil Kim · Johns Hopkins University1 papers (2017–2017)Angela N. Bartley · Trinity Health Ann Arbor Hospital1 papers (2017–2017)Andrew Fire · Stanford University1 papers (2021–2021)Paul G. Rothberg · University of Rochester Medical Center1 papers (2017–2017) · 1 papers (2014–2014)Benjamin J. Strober · Boston Children's Hospital1 papers (2017–2017)Nicholas C. Turner · Queensland University of Technology1 papers (2022–2022)Antoîne Italiano · Institut Bergonié1 papers (2022–2022)Takayuki Yoshino · Kindai University1 papers (2022–2022)Alexis Battle · Johns Hopkins University1 papers (2017–2017)Colby Chiang · Boston Children's Hospital1 papers (2017–2017)